Back to News
Market Impact: 0.5
Marijuana Rescheduling Halted as GAO Report Puts Federal Evaluation Standards Under Scrutiny
Source: Newswire
Regulation & LegislationHealthcare & BiotechLegal & Litigation
A Government Accountability Office review identified deficiencies in DEA and FDA procedures underlying the Department of Health and Human Services' marijuana-rescheduling recommendation. A judge also halted broader marijuana rescheduling, creating additional regulatory and legal uncertainty for cannabis companies and related healthcare stakeholders.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
More News
- California Gov. Gavin Newsom bans AI 'robo bosses' in landmark state law, reversing his earlier veto
- US judge approves settlement allowing Paramount to acquire Warner Bros
- Why is Nidec stock plunging today?
- Nidec Corp shares slump after auditor declines to sign off on earnings
- Google rolls out Gemini 4 Argon, its most advanced AI model
- US judge allows Paramount to close Warner Bros acquisition